RARE Ultragenyx Pharmaceutical Inc. - Common Stock
NASDAQ · Biotechnology · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 5, 2026
$15,22
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$12,7352 haftanın en düşüğü
$39,8952 haftanın en yükseği
Piyasa Değeri (MRQ)
$1.50B
P/E (TTM)
-2.6
Hisse Başına Kâr (TTM)
$-5.83
Gelir (TTM)
$717M
rozetleriniz
52 Haftlık Aralık
$13–$40
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$28
P/E
-2.6
ROE
838.8%
Net Kâr Marjı
-81.7%
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
RARE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$15.22
Piyasa Değeri (MRQ)
$1.50B
P/E (TTM)
-2.6
Hisse Başına Kâr (TTM)
$-5.83
Gelir (TTM)
$717M
ROE (TTM)
838.8%
52 Haftlık Aralık
$13–$40
RARE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir$673M2016-12-31 → 2025-12-31
Hisse Başına Kâr$-5.832020-12-31 → 2025-12-31
Serbest Nakit Akışı$-472M2016-12-31 → 2025-12-31
Net kar marjı-81.7%2016-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | RARE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E (TTM) | -2.65Y ort. ≈-6.7 | ≈-6.7 | · | · | |
| F/S (TTM) | 2.15Y ort. ≈9.0 | ≈9.0 | 11.4 | Düşük değerli | |
| F/D (MRQ) | -5.25Y ort. ≈3.5 | ≈3.5 | · | · | |
| Fiyat / Serbest Nakit Akışı (TTM) | -3.15Y ort. ≈-8.4 | ≈-8.4 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -3.15Y ort. ≈-9.6 | ≈-9.6 | · | · | |
| Fiyat / Maddi Defter Değeri (MRQ) | -3.25Y ort. ≈52.2 | ≈52.2 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | RARE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Faaliyet Kâr Marjı (TTM) | -73.6%5Y ort. ≈-118.7% | ≈-118.7% | -135.5% | En üst düzey | |
| FAVÖK Marjı (TTM) | -69.0%5Y ort. ≈-113.4% | ≈-113.4% | -135.0% | En üst düzey | |
| Vergi Öncesi Kar Marjı (TTM) | -81.2%5Y ort. ≈-129.7% | ≈-129.7% | -206.8% | En üst düzey | |
| Net Kâr Marjı (TTM) | -81.7%5Y ort. ≈-130.1% | ≈-130.1% | -206.9% | En üst düzey | |
| ROA (TTM) | -45.6%5Y ort. ≈-37.9% | ≈-37.9% | -37.9% | Aynı seviyede | |
| ROE (TTM) | 838.8%5Y ort. ≈-483.7% | ≈-483.7% | -44.0% | Zayıf | |
| ROIC | 673.4%5Y ort. ≈6.0% | ≈6.0% | -25.6% | En üst düzey |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | RARE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 1.75Y ort. ≈3.1 | ≈3.1 | 7.2 | Düşük likidite | |
| Quick Ratio (Cari Oran) | 1.55Y ort. ≈1.2 | ≈1.2 | 5.1 | Düşük likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
| Metrik | 5 Yıllık trend | RARE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Revenue YoY (Gelir Yıllık Bazda) | 20.2%5Y ort. ≈20.3% | ≈20.3% | · | · | |
| Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı) | 22.8%5Y ort. ≈18.9% | ≈18.9% | · | · | |
| Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı) | 20.0% | · | · | · |
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
| Metrik | 5 Yıllık trend | RARE | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Asset Turnover (Aktif Devir Hızı) | 0.45Y ort. ≈0.3 | ≈0.3 | 0.3 | En üst düzey | |
| Receivables Turnover (Alacak Devir Hızı) | 4.85Y ort. ≈8.5 | ≈8.5 | 4.8 | Aynı seviyede | |
| Revenue / Employee (Çalışan Başına Gelir) | ≈$490.9K | · | · | · |
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
-5.9%
Sonraki Rapor
Kas 02, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 3, 2026 | $-0.90 | $-1.24 | 27.4% |
| 31 Mart 2026 | $-1.84 | $-1.54 | -19.5% | |
| 31 Aralık 2025 | $-1.29 | $-1.11 | -15.8% | |
| 30 Eylül 2025 | $-1.81 | $-1.26 | -43.7% | |
| 30 Haziran 2025 | $-1.17 | $-1.32 | 11.7% | |
| 31 Mart 2025 | $-1.57 | $-1.65 | 4.6% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $673M | $560M | $434M | $363M | $351M | $271M | $104M | $51M | $3M | $133.0K | |
| Cost of Revenue | · | · | · | · | · | · | · | $1M | $1.0K | · | |
| R&D Expense | $750M | $698M | $648M | $706M | $497M | $412M | $357M | $294M | $232M | $183M | |
| SG&A Expense | $349M | $321M | $310M | $278M | $220M | $183M | $162M | $128M | $100M | $65M | |
| Operating Expenses | · | · | · | · | · | $601M | $528M | $423M | $332M | $248M | |
| Operating Income | $-535M | $-536M | $-569M | $-649M | $-382M | $-330M | $-424M | $-371M | $-329M | $-248M | |
| Interest Income | $25M | $37M | $27M | $11M | $2M | $7M | $13M | $10M | $4M | $4M | |
| Other Non-op | $1M | $-5M | $-1M | $-2M | $-2M | $607.0K | $-787.0K | $-6M | $7M | $-2M | |
| Pretax Income | $-571M | $-567M | $-609M | $-702M | $-453M | $-185M | $-399M | $-197M | $-318M | $-246M | |
| Income Tax | $4M | $2M | $-2M | $6M | $1M | $1M | $3M | $514.0K | $-16M | $35.0K | |
| Net Income | $-575M | $-569M | $-607M | $-707M | $-454M | $-187M | $-403M | $-198M | $-302M | $-246M | |
| EPS (Basic) | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | · | · | · | · | |
| EPS (Diluted) | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | · | · | · | · | |
| Shares (Basic) | 98,600,000 | 90,500,000 | 73,500,000 | 69,914,225 | 67,795,540 | 60,845,550 | · | · | · | · | |
| Shares (Diluted) | 98,600,000 | 90,500,000 | 73,500,000 | 69,914,225 | 67,795,540 | 60,845,550 | · | · | · | · | |
| EBITDA | $-500M | $-500M | $-543M | $-631M | $-368M | $-318M | $-416M | $-352M | $-323M | $-245M |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $421M | $174M | $214M | $133M | $308M | $714M | $434M | $113M | $100M | $161M | |
| Short-term Investments | · | · | · | · | · | · | $322M | $346M | $134M | $219M | |
| Receivables | $158M | $122M | $73M | $40M | $28M | $23M | $33M | $13M | $5M | · | |
| Inventory | $52M | $45M | $34M | $27M | $16M | $13M | $12M | $7M | $757.0K | · | |
| Prepaid Expense | $61M | $40M | $48M | $69M | $72M | $58M | $51M | $43M | $29M | $20M | |
| Other Current Assets | · | · | $48M | $69M | · | · | · | · | · | · | |
| Current Assets | $951M | $817M | $732M | $884M | $857M | $1.30B | $851M | $522M | $270M | $402M | |
| PP&E (Net) | $244M | $266M | $291M | $260M | $141M | $74M | $44M | $20M | $22M | $17M | |
| PP&E (Gross) | $380M | $378M | $374M | $323M | $191M | $111M | $70M | $38M | $33M | $23M | |
| Accum. Depreciation | $136M | $112M | $83M | $63M | $50M | $37M | $26M | $18M | $11M | $6M | |
| Goodwill | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | · | |
| Intangibles | $176M | $178M | $166M | $160M | $131M | $131M | $129M | $129M | $142M | · | |
| Other Non-current Assets | $60M | $63M | $58M | $48M | $21M | $9M | $3M | $4M | $3M | $2M | |
| Total Assets | $1.53B | $1.50B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $720M | $491M | $541M | |
| Accounts Payable | $31M | $39M | $42M | $43M | $17M | $13M | $13M | $12M | $9M | $5M | |
| Accrued Liabilities | $265M | $241M | $196M | $205M | $146M | $108M | $83M | $62M | $62M | $55M | |
| Current Liabilities | $384M | $344M | $280M | $261M | $181M | $190M | $103M | $75M | $71M | $60M | |
| Capital Leases | $24M | $30M | $31M | $20M | $30M | $39M | $30M | · | · | · | |
| Deferred Tax | $30M | $30M | $30M | $32M | $33M | $33M | $33M | $31M | $31M | · | |
| Other Non-current Liabilities | $44M | $17M | $12M | $5M | $1M | $7M | · | $5M | $5M | $6M | |
| Total Liabilities | $1.60B | $1.24B | $1.22B | $1.19B | $600M | $605M | $482M | $111M | $107M | $67M | |
| Common Stock | $0 | $0 | $82.0K | $70.0K | $69.0K | $67.0K | $58.0K | $51.0K | $44.0K | $41.0K | |
| Paid-in Capital | $4.45B | $4.21B | $3.66B | $3.14B | $3.00B | $2.77B | $2.09B | $1.64B | $1.22B | $1.00B | |
| Retained Earnings | $-4.53B | $-3.96B | $-3.39B | $-2.78B | $-2.07B | $-1.62B | $-1.43B | $-1.03B | $-833M | $-531M | |
| Treasury Stock | $8M | $4M | $432.0K | $0 | · | · | · | · | · | · | |
| AOCI | $1M | $-1M | $647.0K | $-7M | $-1M | $689.0K | $-147.0K | $-633.0K | $-6M | $905.0K | |
| Stockholders' Equity | $-80M | $255M | $275M | $352M | $923M | $1.15B | $654M | $609M | $383M | $474M | |
| Liabilities + Equity | $1.53B | $1.50B | $1.49B | $1.55B | $1.52B | $1.76B | $1.14B | $720M | $491M | $541M | |
| Shares Outstanding | 96,600,000 | 92,500,000 | 82,300,000 | 70,200,000 | 69,344,998 | 66,818,520 | 57,838,220 | 50,860,588 | 44,167,071 | 41,240,230 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $35M | $36M | $26M | $18M | $13M | $12M | $9M | $20M | $6M | $3M | |
| Stock-based Comp | · | · | · | · | · | · | · | · | $68M | $48M | |
| Deferred Tax | · | $-1M | $-2M | $2M | · | · | $2M | · | $-16M | · | |
| Other Non-cash | $74M | $118M | $104M | $310M | $102M | $42M | $47M | $-112M | $-9M | $33M | |
| Operating Cash Flow | $-466M | $-414M | $-475M | $-380M | $-339M | $-132M | $-345M | $-291M | $-254M | $-161M | |
| CapEx | $6M | $7M | $44M | $116M | $73M | $44M | $25M | $4M | $3M | $10M | |
| Investing Cash Flow | $236M | $-18M | $168M | $-292M | $-195M | $-179M | $-13M | $-33M | $55M | $91M | |
| Stock Issued | · | · | · | $0 | $0 | $436M | $330M | $271M | · | · | |
| Net Stock Activity | · | · | · | $0 | · | $436M | $330M | $271M | · | · | |
| Financing Cash Flow | $478M | $399M | $388M | $501M | $119M | $600M | $679M | $337M | $136M | $139M | |
| Net Change in Cash | $252M | $-35M | $81M | $-172M | $-417M | $290M | $321M | $12M | $-62M | $69M | |
| Taxes Paid | $4M | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-472M | $-422M | $-519M | $-497M | $-412M | $-176M | $-370M | $-295M | $-257M | $-171M |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -79.5% | -95.7% | -131.1% | -178.6% | -108.6% | -121.8% | -409.0% | -721.2% | -12593.5% | -186471.4% | |
| Net Margin | -85.4% | -101.6% | -139.7% | -194.7% | -129.2% | -68.8% | -388.3% | -383.8% | -11567.3% | -184867.7% | |
| Pretax Margin | -84.8% | -101.3% | -140.1% | -193.1% | -128.9% | -68.4% | -385.1% | -382.8% | -12187.5% | -184841.4% | |
| EBITDA Margin | -74.3% | -89.3% | -125.1% | -173.6% | -104.9% | -117.3% | -400.8% | -683.2% | -12370.5% | -183897.0% | |
| ROA | -37.9% | -38.0% | -40.0% | -46.1% | -27.7% | -12.9% | -43.4% | -32.6% | -58.6% | -44.7% | |
| ROE | -1613.2% | -189.1% | -395.0% | -172.3% | -48.9% | -20.5% | -58.3% | -31.1% | -70.5% | -48.9% | |
| ROIC | 673.4% | -210.5% | -206.1% | -185.6% | -41.5% | -28.8% | -65.4% | -61.2% | -81.4% | -52.3% |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.4 | 2.6 | 3.4 | 4.7 | 6.8 | 8.2 | 7.0 | 3.8 | 6.7 | |
| Quick Ratio | 1.5 | 0.9 | 1.0 | 0.7 | 1.9 | 3.9 | 7.6 | 6.3 | 3.4 | 6.3 |
Verimlilik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.3 | 0.0 | · | |
| Receivables Turnover | 4.8 | 5.7 | 7.6 | 10.6 | 13.6 | 9.7 | 4.6 | 5.7 | 1.0 | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-0.83 | $2.76 | $3.35 | $5.02 | $13.30 | $17.28 | $11.30 | $11.97 | $8.68 | $11.49 | |
| Revenue / Share | $6.83 | $6.19 | $5.90 | $5.20 | · | · | · | · | · | · | |
| Cash Flow / Share | $-4.73 | $-4.57 | $-6.46 | $-5.44 | · | · | · | · | · | · | |
| Cash / Share | $4.36 | $1.88 | $2.59 | $1.89 | $4.44 | $10.68 | $7.50 | $2.23 | $2.28 | $3.91 | |
| EPS (TTM) | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 | $-3.07 | $-7.01 | $-3.91 | · | · |
Büyüme Oranları
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 20.2% | 29.0% | 19.4% | 3.4% | 29.7% | · | · | · | · | · | |
| Revenue CAGR 3Y | 22.8% | 16.8% | 17.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 20.0% | · | · | · | · | · | · | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $673M | $560M | $434M | $363M | $351M | $271M | $104M | $51M | $3M | $133.0K | |
| Net Income TTM | $-575M | $-569M | $-607M | $-707M | $-454M | $-187M | $-403M | $-198M | $-302M | $-246M | |
| Market Cap | $2.22B | $3.89B | $3.94B | $3.25B | $5.83B | $9.25B | $2.47B | $2.21B | $2.05B | $2.90B | |
| P/E | -3.9 | -6.7 | -5.8 | -4.6 | -12.6 | -45.1 | -6.1 | -11.1 | · | · | |
| P/S | 3.3 | 6.9 | 9.1 | 9.0 | 16.6 | 34.1 | 23.8 | 42.9 | 784.3 | 21801.5 | |
| P/B | -27.8 | 15.2 | 14.3 | 9.2 | 6.3 | 8.0 | 3.8 | 3.6 | 5.3 | 6.1 | |
| P / Tangible Book | · | 117.9 | 61.2 | 22.1 | 7.8 | 9.4 | · | · | · | · | |
| P / Cash Flow | -4.8 | -9.4 | -8.3 | -8.5 | -17.2 | -70.0 | -7.2 | -7.6 | -8.1 | -18.0 | |
| P / FCF | -4.7 | -9.2 | -7.6 | -6.5 | -14.2 | -52.5 | -6.7 | -7.5 | -8.0 | -16.9 | |
| Earnings Yield | -25.4% | -14.9% | -17.2% | -21.8% | -8.0% | -2.2% | -16.4% | -9.0% | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $214M | $136M | $207M | $160M | $167M | $139M | $165M | $139M | $147M | $109M | $127M | $98M | $108M | $100M | $103M | $91M | |
| R&D Expense | $167M | $187M | $203M | $216M | $165M | $166M | $188M | $170M | $162M | $178M | $160M | $157M | $165M | $166M | $171M | $237M | |
| SG&A Expense | $88M | $88M | $88M | $87M | $87M | $87M | $82M | $80M | $81M | $78M | $77M | $75M | $81M | $77M | $73M | $70M | |
| Operating Income | $-75M | $-169M | $-113M | $-171M | $-108M | $-143M | $-122M | $-132M | $-116M | $-165M | $-122M | $-145M | $-148M | $-154M | $-146M | $-225M | |
| Interest Income | $5M | $6M | $7M | $6M | $6M | $7M | $10M | $11M | $7M | $9M | $9M | $6M | $6M | $6M | $6M | $3M | |
| Other Non-op | $1M | · | $-934.0K | $-1M | $2M | $837.0K | $-5M | $3M | $-2M | $-2M | $1M | $-699.0K | $-2M | $308.0K | $180.0K | $-1M | |
| Pretax Income | $-91M | $-184M | $-128M | $-180M | $-114M | $-150M | $-133M | $-133M | $-131M | $-170M | $-127M | $-159M | $-159M | $-163M | $-153M | $-239M | |
| Income Tax | $1M | $1M | $870.0K | $873.0K | $1M | $1M | $384.0K | $303.0K | $858.0K | $455.0K | $-4M | $650.0K | $732.0K | $495.0K | $-1M | $6M | |
| Net Income | $-92M | $-185M | $-129M | $-180M | $-115M | $-151M | $-133M | $-134M | $-132M | $-171M | $-124M | $-160M | $-160M | $-164M | $-152M | $-245M | |
| EPS (Basic) | $-0.90 | $-1.84 | $-1.28 | $-1.81 | $-1.17 | $-1.57 | $-1.34 | $-1.40 | $-1.52 | $-2.03 | $-1.44 | $-2.23 | $-2.25 | $-2.33 | $-2.17 | $-3.50 | |
| EPS (Diluted) | $-0.90 | $-1.84 | $-1.28 | $-1.81 | $-1.17 | $-1.57 | $-1.34 | $-1.40 | $-1.52 | $-2.03 | $-1.44 | $-2.23 | $-2.25 | $-2.33 | $-2.17 | $-3.50 | |
| Shares (Basic) | 101,900,000 | 100,600,000 | · | 99,771,297 | 98,500,000 | 96,300,000 | · | 95,493,996 | 86,580,516 | 84,286,292 | · | 71,664,493 | 70,897,991 | 70,368,478 | · | 70,054,173 | |
| Shares (Diluted) | 101,900,000 | 100,600,000 | · | 99,771,297 | 98,500,000 | 96,300,000 | · | 95,493,996 | 86,580,516 | 84,286,292 | · | 71,664,493 | 70,897,991 | 70,368,478 | · | 70,054,173 | |
| EBITDA | $-75M | $-161M | · | $-171M | $-108M | $-134M | · | $-132M | $-116M | $-157M | · | $-145M | $-148M | $-149M | · | $-225M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $125M | $175M | $421M | $203M | $176M | $127M | $174M | $151M | $481M | $112M | $214M | $73M | $102M | $86M | $133M | $392M | |
| Receivables | $200M | $121M | $158M | $113M | $124M | $99M | $122M | $93M | $106M | $100M | · | $79M | $71M | $43M | · | $31M | |
| Inventory | $59M | $55M | $52M | $52M | $46M | $46M | $45M | $43M | $40M | $36M | · | $32M | $28M | $27M | · | $22M | |
| Prepaid Expense | $55M | $68M | $61M | $53M | $61M | $60M | $40M | · | · | · | · | $46M | $51M | $67M | · | $71M | |
| Other Current Assets | · | · | · | · | · | · | · | $41M | $55M | $48M | · | · | · | · | · | · | |
| Current Assets | $606M | $657M | $951M | $643M | $720M | $699M | $817M | $800M | $965M | $596M | · | $599M | $702M | $766M | · | $1.01B | |
| PP&E (Net) | $235M | $239M | $244M | $250M | $256M | $261M | $266M | $272M | $279M | $285M | · | $297M | $289M | $278M | · | $235M | |
| PP&E (Gross) | · | · | $380M | · | · | · | $378M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $136M | · | · | · | $112M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | $44M | · | $44M | $44M | $44M | · | $44M | |
| Intangibles | $172M | $174M | $176M | $173M | $175M | $177M | $178M | $165M | $166M | $165M | · | $157M | $158M | $159M | · | $158M | |
| Other Non-current Assets | $63M | $61M | $60M | $58M | $60M | $62M | $63M | $54M | $54M | $60M | · | $28M | $26M | $22M | · | $18M | |
| Total Assets | $1.26B | $1.30B | $1.53B | $1.19B | $1.31B | $1.31B | $1.50B | $1.54B | $1.62B | $1.31B | · | $1.24B | $1.31B | $1.38B | · | $1.62B | |
| Accounts Payable | $39M | $42M | $31M | $41M | $34M | $47M | $39M | $36M | $60M | $41M | · | $33M | $42M | $59M | · | $24M | |
| Accrued Liabilities | $221M | $194M | $265M | $221M | $181M | $173M | $241M | $185M | $154M | $149M | · | $179M | $168M | $144M | · | $189M | |
| Current Liabilities | $351M | $325M | $384M | $340M | $293M | $292M | $344M | $285M | $273M | $246M | · | $254M | $244M | $218M | · | $227M | |
| Capital Leases | · | · | $24M | $22M | $25M | $28M | $30M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | $30M | · | $32M | $32M | $32M | · | $33M | |
| Other Non-current Liabilities | $41M | $42M | $20M | $19M | $17M | $17M | $17M | $16M | $15M | $14M | · | $10M | $10M | $9M | · | $4M | |
| Total Liabilities | $1.55B | $1.52B | $1.60B | $1.17B | $1.15B | $1.16B | $1.24B | $1.18B | $1.19B | $1.17B | · | $1.21B | $1.18B | $1.16B | · | $1.15B | |
| Common Stock | $0 | $0 | $0 | $96.0K | $96.0K | $94.0K | $0 | $92.0K | $92.0K | $83.0K | · | $72.0K | $71.0K | $71.0K | · | $70.0K | |
| Paid-in Capital | $4.52B | $4.48B | $4.45B | $4.41B | $4.37B | $4.25B | $4.21B | $4.17B | $4.12B | $3.70B | · | $3.30B | $3.24B | $3.17B | · | $3.11B | |
| Retained Earnings | $-4.81B | $-4.72B | $-4.53B | $-4.40B | $-4.22B | $-4.11B | $-3.96B | $-3.82B | $-3.69B | $-3.56B | · | $-3.26B | $-3.10B | $-2.94B | · | $-2.63B | |
| Treasury Stock | $10M | $10M | $8M | $8M | $8M | $8M | $4M | $4M | $3M | $3M | · | $381.0K | $381.0K | $356.0K | · | · | |
| AOCI | $0 | $0 | $1M | $820.0K | $-268.0K | $-341.0K | $-1M | $896.0K | $-1M | $-431.0K | · | $-2M | $-3M | $-4M | · | $-10M | |
| Stockholders' Equity | $-291M | $-236M | $-80M | $9M | $151M | $144M | $255M | $347M | $432M | $140M | $275M | $32M | $129M | $220M | $352M | $469M | |
| Liabilities + Equity | $1.26B | $1.30B | $1.53B | $1.19B | $1.31B | $1.31B | $1.50B | $1.54B | $1.62B | $1.31B | · | $1.24B | $1.31B | $1.38B | · | $1.62B | |
| Shares Outstanding | 98,600,000 | 98,300,000 | 96,600,000 | 96,442,027 | 96,353,634 | 93,903,785 | 92,500,000 | 92,304,317 | 92,135,384 | 83,094,037 | 82,300,000 | 72,174,307 | 71,465,424 | 70,660,249 | 70,197,297 | 70,079,777 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $8M | $9M | $9M | $9M | $9M | $10M | $9M | $9M | $9M | $8M | $7M | $5M | $5M | $5M | $5M | |
| Other Non-cash | · | $-20M | · | · | · | $-24M | · | · | · | $-29M | · | · | · | $2M | · | · | |
| Operating Cash Flow | $-97M | $-197M | $-100M | $-91M | $-108M | $-166M | $-79M | $-67M | $-77M | $-191M | $-84M | $-118M | $-116M | $-157M | $-90M | $-95M | |
| CapEx | $1M | $1M | $938.0K | $1M | $2M | $1M | $163.0K | $2M | $2M | $3M | $1M | $4M | $14M | $25M | $27M | $26M | |
| Investing Cash Flow | $44M | $-49M | $-72M | $117M | $71M | $120M | $103M | $-276M | $61M | $94M | $-107M | $64M | $99M | $111M | $-172M | $-162M | |
| Financing Cash Flow | · | · | $394M | $2.0K | $84M | $157.0K | $3M | $11M | $385M | $-58.0K | $330M | $25M | $33M | $-722.0K | $2M | $492M | |
| Net Change in Cash | $-49M | $-247M | $221M | $26M | $49M | $-45M | $24M | $-330M | $368M | $-97M | $140M | $-29M | $16M | $-46M | $-259M | $234M | |
| Free Cash Flow | · | $-198M | · | · | · | $-168M | · | · | · | $-194M | · | · | · | $-182M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -35.0% | -124.3% | · | -106.8% | -64.8% | -102.6% | · | -94.6% | -79.1% | -151.9% | · | -148.0% | -136.6% | -153.3% | · | -248.1% | |
| Net Margin | -43.0% | -136.0% | · | -112.8% | -69.0% | -108.5% | · | -95.7% | -89.5% | -156.8% | · | -162.8% | -147.6% | -163.2% | · | -270.2% | |
| Pretax Margin | -42.5% | -135.3% | · | -112.3% | -68.5% | -107.5% | · | -95.5% | -88.9% | -156.4% | · | -162.2% | -146.9% | -162.7% | · | -263.3% | |
| EBITDA Margin | -35.0% | -118.4% | · | -106.8% | -64.8% | -96.2% | · | -94.6% | -79.1% | -143.8% | · | -148.0% | -136.6% | -148.1% | · | -248.1% | |
| ROA | -7.2% | -14.2% | · | -13.2% | -7.9% | -11.5% | · | -9.6% | -9.0% | -12.7% | · | -11.2% | -12.2% | -11.8% | · | -15.8% | |
| ROE | 131.7% | 403.2% | · | -101.4% | -39.4% | -106.2% | · | -70.5% | -46.9% | -94.6% | · | -63.8% | -39.6% | -32.2% | · | -34.9% | |
| ROIC | 26.1% | 72.0% | · | -1874.9% | -71.9% | -100.0% | · | -38.1% | -27.1% | -118.2% | · | -459.4% | -115.2% | -70.1% | · | -49.3% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.7 | 2.0 | · | 1.9 | 2.5 | 2.4 | · | 2.8 | 3.5 | 2.4 | · | 2.4 | 2.9 | 3.5 | · | 4.5 | |
| Quick Ratio | 0.9 | 0.9 | · | 0.9 | 1.0 | 0.8 | · | 0.9 | 2.1 | 0.9 | · | 0.6 | 0.7 | 0.6 | · | 1.9 |
Verimlilik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Receivables Turnover | 1.3 | 1.2 | · | 1.6 | 1.4 | 1.4 | · | 1.6 | 1.7 | 1.5 | · | 1.8 | 2.0 | 2.8 | · | 3.2 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-2.95 | $-2.40 | · | $0.10 | $1.57 | $1.54 | · | $3.76 | $4.69 | $1.69 | · | $0.44 | $1.81 | $3.12 | · | $6.69 | |
| Revenue / Share | $2.10 | $1.35 | · | $1.60 | $1.69 | $1.45 | · | $1.46 | $1.70 | $1.29 | · | $1.37 | $1.53 | $1.43 | · | $1.29 | |
| Cash Flow / Share | · | $-1.96 | · | · | · | $-1.73 | · | · | · | $-2.26 | · | · | · | $-2.23 | · | · | |
| Cash / Share | $1.27 | $1.78 | · | $2.10 | $1.83 | $1.35 | · | $1.63 | $5.22 | $1.35 | · | $1.01 | $1.43 | $1.21 | · | $5.59 | |
| EPS (TTM) | $-5.83 | $-6.10 | · | $-5.89 | $-5.48 | $-5.83 | · | $-6.39 | $-7.22 | $-7.95 | · | $-8.98 | $-10.25 | $-10.26 | · | $-9.74 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $717M | $670M | · | $631M | $610M | $590M | · | $522M | $481M | $442M | · | $410M | $403M | $384M | · | $343M | |
| Net Income TTM | $-586M | $-609M | · | $-580M | $-533M | $-549M | · | $-559M | $-585M | $-614M | · | $-635M | $-721M | $-719M | · | $-678M | |
| Market Cap | $3.29B | $2.06B | · | $2.90B | $3.50B | $3.40B | · | $5.13B | $3.79B | $3.88B | · | $2.57B | $3.30B | $2.83B | · | $2.90B | |
| P/E | -5.7 | -3.4 | · | -5.1 | -6.6 | -6.2 | · | -8.7 | -5.7 | -5.9 | · | -4.0 | -4.5 | -3.9 | · | -4.3 | |
| P/S | 4.6 | 3.1 | · | 4.6 | 5.7 | 5.8 | · | 9.8 | 7.9 | 8.8 | · | 6.3 | 8.2 | 7.4 | · | 8.5 | |
| P/B | -11.3 | -8.7 | · | 316.7 | 23.2 | 23.6 | · | 14.8 | 8.8 | 27.7 | · | 81.1 | 25.5 | 12.9 | · | 6.2 | |
| P / Tangible Book | · | · | · | · | · | · | · | 37.3 | 17.1 | · | · | · | · | 167.6 | · | 10.9 | |
| P / Cash Flow | · | -10.5 | · | · | · | -20.4 | · | · | · | -20.3 | · | · | · | -18.1 | · | · | |
| Earnings Yield | -17.5% | -29.1% | · | -19.6% | -15.1% | -16.1% | · | -11.5% | -17.6% | -17.0% | · | -25.2% | -22.2% | -25.6% | · | -23.5% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Gelir | $673M | $560M | $434M | $363M | $351M |
| Faaliyet Kâr Marjı % | -79.5% | -95.7% | -131.1% | -178.6% | -108.6% |
| Net Gelir | $-575M | $-569M | $-607M | $-707M | $-454M |
| Seyreltilmiş Hisse Başı Kâr | $-5.83 | $-6.29 | $-8.25 | $-10.12 | $-6.70 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 2.5 | 2.4 | 2.6 | 3.4 | 4.7 |
| Cari Oran | 1.5 | 0.9 | 1.0 | 0.7 | 1.9 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-472M | $-422M | $-519M | $-497M | $-412M |
Kurumsal Sahipler (13F) 344 dosya · $3.8B toplam · Tarih itibarıyla 30 Eylül 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
344
Tutulan Değer
$3.8B
Yeni pozisyonlar
63
Çıkan pozisyonlar
37
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 63 (-2 önceki Ç'ye göre) | 37 (-8 önceki Ç'ye göre) | 120 (-9 önceki Ç'ye göre) | 100 (+13 önceki Ç'ye göre) | +10.3M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BlackRock, Inc. | $355.746.262 | 10.654.276 | 9,26% | Hisse senetleri |
| RTW INVESTMENTS, LP | $260.338.324 | 7.796.895 | 6,77% | Hisse senetleri |
| VANGUARD GROUP INC | $236.067.745 | 10.263.815 | 6,14% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $226.722.608 | 6.790.135 | 5,90% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $214.144.806 | 6.560.809 | 5,57% | Hisse senetleri |
| STATE STREET CORP | $205.641.197 | 6.158.766 | 5,35% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $143.459.834 | 4.296.491 | 3,73% | Hisse senetleri |
| TWO SIGMA INVESTMENTS, LP | $120.911.868 | 3.621.200 | 3,15% | Hisse senetleri |
| SANDS CAPITAL MANAGEMENT, LLC | $105.457.908 | 3.158.368 | 2,74% | Hisse senetleri |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $98.157.217 | 2.939.719 | 2,55% | Hisse senetleri |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $95.092.590 | 2.847.936 | 2,47% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $86.123.888 | 2.578.828 | 2,24% | Hisse senetleri |
| Bellevue Group AG | $66.204.857 | 1.982.775 | 1,72% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $57.771.145 | 1.730.193 | 1,50% | Hisse senetleri |
| Sofinnova Investments, Inc. | $57.347.492 | 1.717.505 | 1,49% | Hisse senetleri |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $52.756.200 | 1.580.000 | 1,37% | Hisse senetleri |
| MPM BIOIMPACT LLC | $47.354.199 | 1.418.215 | 1,23% | Hisse senetleri |
| MORGAN STANLEY | $44.235.265 | 1.324.805 | 1,15% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $41.752.993 | 1.250.464 | 1,09% | Hisse senetleri |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $41.455.555 | 1.241.556 | 1,08% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $38.346.863 | 1.148.454 | 1,00% | Hisse senetleri |
| Candriam S.C.A. | $33.419.286 | 1.001.841 | 0,87% | Hisse senetleri |
| Rock Springs Capital Management LP | $32.316.678 | 967.855 | 0,84% | Hisse senetleri |
| Jefferies Financial Group Inc. | $31.040.212 | 929.626 | 0,81% | Hisse senetleri |
| NORTHERN TRUST CORP | $30.729.285 | 920.314 | 0,80% | Hisse senetleri |
| Eagle Health Investments LP | $29.520.800 | 884.121 | 0,77% | Hisse senetleri |
| Qube Research & Technologies Ltd | $29.457.292 | 882.219 | 0,77% | Hisse senetleri |
| Russell Investments Group, Ltd. | $26.181.069 | 784.099 | 0,68% | Hisse senetleri |
| MILLENNIUM MANAGEMENT LLC | $25.403.947 | 760.825 | 0,66% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25.377.702 | 760.039 | 0,66% | Hisse senetleri |
| Caption Management, LLC | $24.000.732 | 718.800 | 0,62% | Satım opsiyonu |
| Nuveen, LLC | $23.171.291 | 693.959 | 0,60% | Hisse senetleri |
| Pictet Asset Management Holding SA | $23.159.948 | 753.695 | 0,60% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $22.418.413 | 671.411 | 0,58% | Hisse senetleri |
| UBS Group AG | $21.960.569 | 657.699 | 0,57% | Hisse senetleri |
| GREAT POINT PARTNERS LLC | $20.034.000 | 600.000 | 0,52% | Satım opsiyonu |
| Palo Alto Investors LP | $19.916.968 | 596.495 | 0,52% | Hisse senetleri |
| SPHERA FUNDS MANAGEMENT LTD. | $19.649.815 | 588.494 | 0,51% | Hisse senetleri |
| Legal & General Group Plc | $19.583.902 | 586.520 | 0,51% | Hisse senetleri |
| PANAGORA ASSET MANAGEMENT INC | $19.574.220 | 586.230 | 0,51% | Hisse senetleri |
| FMR LLC | $19.260.990 | 576.849 | 0,50% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $19.210.535 | 575.338 | 0,50% | Hisse senetleri |
| Trexquant Investment LP | $18.577.695 | 556.385 | 0,48% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16.995.510 | 509.000 | 0,44% | Satım opsiyonu |
| Sofinnova Investments, Inc. | $16.695.000 | 500.000 | 0,43% | Alım opsiyonu |
| BNP PARIBAS FINANCIAL MARKETS | $16.633.796 | 498.167 | 0,43% | Hisse senetleri |
| Bank of New York Mellon Corp | $15.716.566 | 470.697 | 0,41% | Hisse senetleri |
| JPMORGAN CHASE & CO | $15.268.024 | 493.126 | 0,40% | Hisse senetleri |
| TORONTO DOMINION BANK | $13.856.850 | 415.000 | 0,36% | Hisse senetleri |
| RENAISSANCE TECHNOLOGIES LLC | $13.813.443 | 413.700 | 0,36% | Hisse senetleri |
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 06 Kasım 2020 | · | İlk başvuru | Pasif yatırım | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 28 içeriden öğrenenler · 15 yöneticiler · 11 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Emil D Kakkis | President & CEO | 16 Nisan 2026 A | 735.739 | 0 | 1 | $-1.240.411 |
| Howard Horn | Chief Financial Officer | 03 Ağustos 2026 S | 96.295 | 0 | 12 | $-1.332.021 |
| Mardi Dier | CFO & Executive Vice President | 14 Ekim 2022 S | 66.695 | 0 | 0 | $0 |
| Wladimir Hogenhuis | Chief Operating Officer | 04 Ekim 2019 F | 18.703 | 0 | 0 | $0 |
| Theodore Alan Huizenga | SVP, Chief Accounting Officer | 15 Eylül 2026 S | 67.863 | 0 | 4 | $-59.794 |
| Karah Herdman Parschauer | EVP and Chief Legal Officer | 03 Ağustos 2026 S | 92.562 | 0 | 5 | $-487.890 |
| Eric Crombez | EVP and Chief Medical Officer | 05 Mayıs 2026 S | 111.189 | 0 | 2 | $-168.847 |
| Erik Harris | EVP & Chief Commercial Officer | 16 Nisan 2026 A | 118.410 | 0 | 1 | $-240.289 |
| John Richard Pinion | EVP, Chief Quality Operations Officer | 16 Nisan 2026 A | 133.142 | 0 | 1 | $-228.661 |
| Dennis Karl Huang | EVP, Chief Technical Operations Officer | 16 Nisan 2026 A | 147.845 | 0 | 0 | $0 |
| Thomas Richard Kassberg | CBO & EVP | 03 Mart 2025 F | 264.730 | 0 | 0 | $0 |
| Camille L Bedrosian | EVP and Chief Medical Officer | 01 Mart 2023 S | 46.720 | 0 | 0 | $0 |
| Shalini Sharp | EVP, Finance | 14 Ekim 2020 S | 97.812 | 0 | 0 | $0 |
| Jayson Donald Alexander Dallas | EVP & Chief Commercial Officer | 01 Haziran 2018 F | 23.830 | 0 | 0 | $0 |
| Sunil Agarwal | Chief Medical Officer | 19 Ağustos 2016 F | 9.136 | 0 | 0 | $0 |
| Corazon (Corsee) D. Sanders | Yönetim kurulu üyesi | 15 Haziran 2026 S | 21.095 | 0 | 1 | $-50.100 |
| Amrit Ray | Yönetim kurulu üyesi | 14 Mayıs 2026 A | 31.116 | 0 | 0 | $0 |
| Shehnaaz Suliman | Yönetim kurulu üyesi | 14 Mayıs 2026 A | 27.951 | 0 | 1 | $-144.189 |
| Deborah Dunsire | Yönetim kurulu üyesi | 14 Mayıs 2026 A | 38.566 | 0 | 0 | $0 |
| Daniel G Welch | Yönetim kurulu üyesi | 14 Mayıs 2026 A | 40.441 | 0 | 0 | $0 |
| Lars Ekman | Yönetim kurulu üyesi | 24 Haziran 2022 A | 17.745 | 0 | 0 | $0 |
| William Aliski | Yönetim kurulu üyesi | 24 Haziran 2021 A | 66.849 | 0 | 0 | $0 |
| Clay B Siegall | Yönetim kurulu üyesi | 10 Ağustos 2020 M | 2.550 | 0 | 0 | $0 |
| Eran Nadav | Yönetim kurulu üyesi | 10 Temmuz 2014 A | · | 0 | 0 | $0 |
| Marten Steen | Yönetim kurulu üyesi | 30 Ocak 2014 A | · | 0 | 0 | $0 |
| Matthew K Fust | · | 14 Mayıs 2026 A | 33.696 | 0 | 0 | $0 |
| Michael Narachi | · | 14 Mayıs 2026 A | 40.441 | 0 | 0 | $0 |
| FMR LLC | · | 01 Ağustos 2014 J | 1.457.994 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 37 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| BBP · ETFis Series Trust I | 1,41% | 55.734 NS | 31 Temmuz 2026 | N-PORT |
| HAPS · Harbor ETF Trust | 1,06% | 72.355 NS | 31 Temmuz 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,63% | 124.269 NS | 31 Temmuz 2026 | N-PORT |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,30% | 154.710 NS | 31 Temmuz 2026 | N-PORT |
| ESSC · Strategy Shares | 0,27% | 3.948 NS | 31 Temmuz 2026 | N-PORT |
| PWS · Pacer Funds Trust | 0,18% | 1.698 NS | 31 Temmuz 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,11% | 202.979 SH | 02 Ekim 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,11% | 46.526 SH | 19 Ağustos 2026 | Günlük |
| BKSE · BNY Mellon ETF Trust | 0,10% | 3.532 NS | 31 Temmuz 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 556.246 SH | 19 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,10% | 6.956 SH | 02 Ekim 2026 | Günlük |
| IBB · iShares Trust | 0,10% | 687.817 SH | 11 Eylül 2026 | Günlük |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,10% | 52.252 NS | 31 Temmuz 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 26.477 NS | 31 Temmuz 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,09% | 1.238.640 SH | 19 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,09% | 46.723 SH | 19 Ağustos 2026 | Günlük |
| RSSL · Global X Funds | 0,08% | 46.288 NS | 31 Temmuz 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,06% | 14.014 NS | 31 Temmuz 2026 | N-PORT |
| IWM · iShares Trust | 0,05% | 2.465.688 SH | 11 Eylül 2026 | Günlük |
| IWO · iShares Trust | 0,04% | 405.050 SH | 11 Eylül 2026 | Günlük |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1.127.405 SH | 19 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,04% | 2.146.622 SH | 19 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,04% | 251.571 SH | 19 Ağustos 2026 | Günlük |
| ESML · iShares Trust | 0,03% | 61.868 SH | 11 Eylül 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 39.676 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,02% | 10.407 SH | 11 Eylül 2026 | Günlük |
| WSML · iShares Trust | 0,01% | 5.013 SH | 11 Eylül 2026 | Günlük |
| ESGV · VANGUARD WORLD FUND | 0,01% | 21.519 SH | 19 Ağustos 2026 | Günlük |
| ITOT · iShares Trust | 0,00% | 140.625 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 25.782 SH | 10 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,00% | 158 NS | 31 Temmuz 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.987.783 SH | 19 Ağustos 2026 | Günlük |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 76.072 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 8.035 SH | 19 Ağustos 2026 | Günlük |
| IWN · iShares Trust | · | 493.596 SH | 11 Eylül 2026 | Günlük |
| ISCB · iShares Trust | · | 4.391 SH | 11 Eylül 2026 | Günlük |
| ISCV · iShares Trust | · | 14.131 SH | 11 Eylül 2026 | Günlük |
RARE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 26 analist
AL
Medyan hedef
$28.00
+84,0%
9 34,6%
Güçlü Al
14 53,8%
Al
3 11,5%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
19 analist · 2026-10-03Ortalama hedef $28.05 +84,3%
← Tüm hedeflerin altında
Mevcut fiyat $15.22
Düşük$18.00
Ortalama$28.05
Yüksek$40.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| RARE | $2.22B | -3.9 | 20.2% | -85.4% | -1613.2% | · |
| ZYME | $1.97B | -24.4 | 38.9% | -76.6% | -26.9% | · |
| XNCR | $1.10B | -12.3 | 13.7% | -73.2% | -14.0% | · |
| SNDX | $1.84B | -6.4 | 627.8% | -165.6% | -257.1% | · |
| TSHA | $1.57B | -16.2 | 17.3% | -1115.3% | -44.0% | · |
| ANAB | · | -105.4 | 157.0% | · | · | · |
| COAG | · | · | · | · | · | · |
| INBX | $1.15B | -8.7 | 550.0% | -10773.5% | -365.9% | · |
| TYRA | $1.41B | -13.1 | · | · | -42.7% | · |
| AVBP | $854M | -4.7 | · | · | -59.7% | · |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 5, 2026